HIV-infected patients, n=71 Non-HIV controls n=71 p
Age, years 45 (40, 49) 45 (39, 50) 0.727
Sex male (%) 59 (83.09) 56 (78.87) 0.335
Framingham risk Score 7 (1, 14) 8 (8.61) 0.368
Current Smokers (%) 38 (53.52) 26 (36.61) 0.035
Hypertension (%) 29 (40.84) 25 (35.21) 0.302
Dyslipidemia (%) 39 (54.92) 36 (50.7) 0.490
Type 2 Diabetes (%) 5 (7.04) 7 (9,85) 0.194
Total Cholesterol, mg/dl 189 (153, 218) 194 (171, 234) 0.010
LDL cholesterol, mg/dl 110 (82, 134) 122 (103, 148) 0.033
Tryglicerides, mg/dl 139 (83, 212) 110 (79, 169) 0.946
HDL cholesterol, mg/dl 42.5 (37.7, 53) 46.5 (39.7, 57) 0.312
Body mass index, kg/m2 24.26 (21, 27.5) 26.15 (23.8, 28) 0.612
Waist circumference, cm 87 (80, 95) 91.5 (81.4, 98) 0.364
sPLA-2 (pg/ml) 8.35  (5.36, 9.6) 1.22 (0.59, 2.62) <0.001
VCAM (ng/ml) 945.63 (655.9, 1404.05) 678.35 (530.39, 831.04) <0.001
hsCRP (mg/L) 3.3 (1.27, 5.28) 3.05 (2.68, 3.27) 0.05
SOD (U/mL) 0.29 (0.25, 0.35) 0.41 (0.31, 0.5) 0.008
TBARS (uM/L) 1.69  (1.39, 1.97) 7.47 (5.03, 10.4) <0.001
Adiponectin (ug/mL) 8.53 (5.9, 11.29) 8.47 (6.4, 10,3) 0.919
Resistin (ng/ml) 4.93 (4.02, 5.86) 5.89 (3.07, 6.3) 0.282
Results are expressed as median (IQR) or number (%).
VCAM, vascular cell adhesion molecule; sPLA2, secretory phospholipase A2; hsCRP, high sensitivity C-reactive protein; SOD, Superoxide dismutases: TBARS, thiobarbituric acid reactive
Table 1: Clinical characteristics, fasting metabolic parameters and biomarkers of HIV infected patients and healthy control group.
Goto home»